Browse Drug Recalls
2,002 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,002 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,002 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jan 24, 2019 | LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), ... | Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date an... | Class II | US Compounding Inc |
| Jan 16, 2019 | NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF), 4 mg / 250 mL, 250 ... | Labeling: Label mix-up | Class II | KRS Global Biotechnology, Inc |
| Jan 16, 2019 | NORepinephrine 16 mg added to 0.9% Sodium Chloride (PF), 16 mg / 250 mL, 250 ... | Labeling: Label mix-up | Class II | KRS Global Biotechnology, Inc |
| Jan 16, 2019 | Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards,... | Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate S... | Class II | Rx Pak Division of McKesson Corporation |
| Jan 15, 2019 | HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodiu... | Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/5... | Class II | Advanced Pharma Inc. |
| Jan 15, 2019 | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 ... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled. | Class II | Tris Pharma Inc. |
| Jan 15, 2019 | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 ... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled. | Class II | Tris Pharma Inc. |
| Jan 15, 2019 | infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 m... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled. | Class II | Tris Pharma Inc. |
| Dec 26, 2018 | LOPERAMIDE HCL TABLETS USP, 2 mg, ANTI-DIARRHEAL, 24 caplets per carton, OTC... | Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel i... | Class III | Sun Pharmaceutical Industries, Inc. |
| Dec 11, 2018 | Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: K... | Labeling: Wrong bar code | Class II | KVK-Tech, Inc. |
| Dec 11, 2018 | Dyural-80 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Eno... | Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recall... | Class I | Asclemed USA Inc. dba Enovachem |
| Dec 11, 2018 | Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Eno... | Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recall... | Class I | Asclemed USA Inc. dba Enovachem |
| Dec 10, 2018 | Monsel's (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as o... | Superpotent Drug: contains higher levels of Iron than labeled. | Class II | Gordon Laboratories |
| Nov 29, 2018 | Phenylephrine HCl, 1 mg in Sterile Water for Injection, QS 10mL Injectable So... | Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as "10 mcg per ... | Class I | Advanced Pharma Inc. |
| Nov 15, 2018 | SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 2... | Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect state... | Class I | Fresenius Kabi USA, LLC |
| Nov 15, 2018 | SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 2... | Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect state... | Class I | Fresenius Kabi USA, LLC |
| Nov 9, 2018 | Medi-Stat Foam, Antimicrobial Hand Soap, Chloroxylenol 0.5%, 1250 mL (42.3 fl... | Labeling: Label mix-up - the label on the product may not match the formula in the bottle. | Class II | Ecolab Inc |
| Nov 9, 2018 | Equi-Soft Foam, Antimicrobial Hand Soap, 0.55% Benzalkonium Chloride, 25 fl o... | Labeling: Label mix-up - the label on the product may not match the formula in the bottle. | Class II | Ecolab Inc |
| Nov 8, 2018 | ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use v... | Labeling: Missing label; potential for missing primary container label on the vial. | Class III | Eli Lilly & Co |
| Nov 2, 2018 | curaplex Epi Safe Kit, 8600-01101, contains:" 1ml Vial of Epinephrine " 1 Ep... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 ... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY, Rx Only, Distributed by Sarn... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Curaplex Epi Kit NOT FOR IV USE, #8600-01120, Epi-Safe Kit 8600-01 120 contai... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 1, 2018 | Curaplex Epi Safe Kit, Rx Only, contains: 1mL Vial of Epinephrine, 1 Epi-Safe... | Labeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly labeled as expiring May... | Class III | Bound Tree Medical, LLC |
| Nov 1, 2018 | curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains... | Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 e... | Class II | Bound Tree Medical, LLC |
| Oct 26, 2018 | Levetiracetam in 0.54 % Sodium Chloride Injection 1,500/mg/100mL (15mg/mL), F... | Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and ... | Class I | Dr. Reddy's Laboratories, Inc. |
| Oct 23, 2018 | Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets, 0.5 mg/0.035 mg,... | Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser cont... | Class II | Janssen Pharmaceuticals, Inc. |
| Oct 23, 2018 | Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28... | Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser cont... | Class II | Janssen Pharmaceuticals, Inc. |
| Oct 3, 2018 | Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g T... | Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Hep... | Class II | Pfizer Inc. |
| Sep 28, 2018 | Tesamorelin, 1mg/vial, 6mL vial, Lyophilized Powder for Reconstitution and Su... | Labeling: Incorrect or Missing Lot and/or Expiration Date; vial indicates a 1 year expiration dat... | Class II | Tailor Made Compounding |
| Sep 25, 2018 | Progesterone SR 100 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw ... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pi... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Progesterone SR 200 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw ... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Tadalafil SR 12 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top p... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 18, 2018 | Altavera Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 m... | Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging com... | Class III | Xiromed LLC |
| Sep 17, 2018 | treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for... | Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabel... | Class III | Otsuka Pharmaceutical Development & Commerciali... |
| Sep 17, 2018 | treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for ... | Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabel... | Class III | Otsuka Pharmaceutical Development & Commerciali... |
| Sep 17, 2018 | robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, ... | Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly... | Class I | Endo Pharmaceuticals, Inc. |
| Aug 27, 2018 | Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3... | Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs. | Class III | Mylan Pharmaceuticals Inc. |
| Aug 23, 2018 | Children s Advil Suspension Ibuprofen Oral Suspension, 100 mg per 5mL, 4 FL O... | Labeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the i... | Class II | Pfizer Global Supply |
| Aug 22, 2018 | THYROID POWDER USP, Full Strength (Levothyroxine labeled range of 103-125mcg/... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Syntec Pharma Corp |
| Aug 22, 2018 | THYROID POWDER USP (Levothyroxine labeled range of 34.2-41.8mcg/grain; Liothy... | CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... | Class II | Syntec Pharma Corp |
| Aug 21, 2018 | Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufact... | Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets US... | Class I | Accord Healthcare, Inc. |
| Aug 21, 2018 | Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx ... | Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary cont... | Class III | Mayne Pharma Inc |
| Aug 15, 2018 | Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero... | Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 ... | Class I | Hetero Labs Limited Unit V |
| Aug 3, 2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100... | Failed Content Uniformity Specifications: Product was manufactured using an adulterated active ph... | Class I | Westminster Pharmaceuticals LLC |
| Aug 3, 2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100... | Failed Content Uniformity Specifications: Product was manufactured using an adulterated active ph... | Class I | Westminster Pharmaceuticals LLC |
| Aug 3, 2018 | Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Dis... | Subpotent drug: The product active ingredient level not matching the exact levels indicated on th... | Class III | Huijing (Shanghai) Bio-tech Co., Ltd. |
| Aug 3, 2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg),... | Failed Content Uniformity Specifications: Product was manufactured using an adulterated active ph... | Class I | Westminster Pharmaceuticals LLC |
| Aug 3, 2018 | Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-... | Failed Content Uniformity Specifications: Product was manufactured using an adulterated active ph... | Class I | Westminster Pharmaceuticals LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.